CESAR ANTONIO PEREZ ESTUDILLO

Dr. CESAR ANTONIO PEREZ ESTUDILLO

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2022 in NeuroSci
Verified
Journal Article
Open access
PDF file
SLSandra Yasbeth Lara
Sandra Yasbeth Lara
ÁFÁngel de Jesús Laureani Fierro
Ángel de Jesús Laureani Fierro
GAGonzalo Aranda-Abreu
Gonzalo Aranda-Abreu
María Rebeca Toledo-CardenasMaría Rebeca Toledo-Cardenas
María Rebeca Toledo-Cardenas
Luis I. GarcíaLuis I. García
Luis I. García
CECESAR ANTONIO PEREZ ESTUDILLO
CESAR ANTONIO PEREZ ESTUDILLO
For years, the biochemical processes that are triggered by harmful and non-harmful stimuli at the central nervous system level have been extensively studied by the scientific community through numerous techniques and animal models. For example, one of these techniques is the use of immediate expression genes, which is a useful, accessible, and reliable method for observing and quantifying cell activation. It has been shown that both the c-fos gene and its protein c-Fos have rapid activation after stimulus, with the length of time that they remain active depending on the type of stimulus and the activation time depending on the stimulus and the structure studied. Fos requires the participation of other genes (such as c-jun) for its expression (during hetero-dimer forming). c-Fos dimerizes with c-Jun protein to form factor AP-1, which promotes the transcription of various genes. The production and removal of c-Fos is part of cellular homeostasis, but its overexpression results in increased cell proliferation. Although Fos has been used as a marker of cellular activity since the 1990s, which molecular mechanism participates in the regulation of the expression of this protein is still unknown because the gene and the protein are not specific to neurons or glial cells. For these reasons, this work has the objective of gathering information about this protein and its use in neuroscience.

1 March 2016 in Physiology & Behavior
Verified
Journal Article
Closed access
MPMiguel Perez-Pouchoulen
Miguel Perez-Pouchoulen
María Rebeca Toledo-CardenasMaría Rebeca Toledo-Cardenas
María Rebeca Toledo-Cardenas
Luis I. GarcíaLuis I. García
Luis I. García
CECESAR ANTONIO PEREZ ESTUDILLO
CESAR ANTONIO PEREZ ESTUDILLO
Genaro Alfonso Coria-AvilaGenaro Alfonso Coria-Avila
Genaro Alfonso Coria-Avila
Jorge ManzoJorge Manzo
Jorge Manzo

8 March 2024 in NeuroSci
Verified
Journal Article
Open access
PDF file
David Brash-AriasDavid Brash-Arias
David Brash-Arias
Luis I. GarcíaLuis I. García
Luis I. García
CECESAR ANTONIO PEREZ ESTUDILLO
CESAR ANTONIO PEREZ ESTUDILLO
FRFausto Rojas-Durán
Fausto Rojas-Durán
GAGonzalo Aranda-Abreu
Gonzalo Aranda-Abreu
Lizbeth Chi-CastañedaLizbeth Chi-Castañeda
Lizbeth Chi-Castañeda
The search for new therapies to reduce symptoms and find a cure for Parkinson’s disease has focused attention on two key points: the accumulation of alpha-synuclein aggregates and astrocytes. The former is a hallmark of the disease, while the latter corresponds to a type of glial cell with an important role in both the prevention and development of this neurodegenerative disorder. Traditionally, research has focused on therapies targeting dopaminergic neurons. Currently, as more is known about the genetic and molecular factors and the neuroglial interaction in the disease, great emphasis has been placed on the neuroprotective role of astrocytes in the early stages of the disease and on the astrocytic capture of alpha-synuclein under both physiological and pathological conditions. This review aims to analyze the contribution of alpha-synuclein and astrocytes to the development and progression of Parkinson’s disease, as well as to evaluate recent therapeutic proposals specifically focused on synucleopathies and astroglial cells as potential therapies for the disease.

28 December 2023 in NeuroSci
Verified
Journal Article
Open access
PDF file
HLHugo Libreros
Hugo Libreros
Jorge ManzoJorge Manzo
Jorge Manzo
FRFausto Rojas-Durán
Fausto Rojas-Durán
GAGonzalo Aranda-Abreu
Gonzalo Aranda-Abreu
Luis I. GarcíaLuis I. García
Luis I. García
MHMaria Elena Hernandez-Aguilar
Maria Elena Hernandez-Aguilar
The twelve cranial nerves play a crucial role in the nervous system, orchestrating a myriad of functions vital for our everyday life. These nerves are each specialized for particular tasks. Cranial nerve I, known as the olfactory nerve, is responsible for our sense of smell, allowing us to perceive and distinguish various scents. Cranial nerve II, or the optic nerve, is dedicated to vision, transmitting visual information from the eyes to the brain. Eye movements are governed by cranial nerves III, IV, and VI, ensuring our ability to track objects and focus. Cranial nerve V controls facial sensations and jaw movements, while cranial nerve VII, the facial nerve, facilitates facial expressions and taste perception. Cranial nerve VIII, or the vestibulocochlear nerve, plays a critical role in hearing and balance. Cranial nerve IX, the glossopharyngeal nerve, affects throat sensations and taste perception. Cranial nerve X, the vagus nerve, is a far-reaching nerve, influencing numerous internal organs, such as the heart, lungs, and digestive system. Cranial nerve XI, the accessory nerve, is responsible for neck muscle control, contributing to head movements. Finally, cranial nerve XII, the hypoglossal nerve, manages tongue movements, essential for speaking, swallowing, and breathing. Understanding these cranial nerves is fundamental in comprehending the intricate workings of our nervous system and the functions that sustain our daily lives.

1 February 2014 in Epilepsy & Behavior
Verified
Journal Article
Closed access
MLMaría-Leonor López-Meraz
María-Leonor López-Meraz
JMJesus-Servando Medel-Matus
Jesus-Servando Medel-Matus
CVConsuelo Morgado Valle
Consuelo Morgado Valle
LBLuis Beltran-Parrazal
Luis Beltran-Parrazal
CECESAR ANTONIO PEREZ ESTUDILLO
CESAR ANTONIO PEREZ ESTUDILLO
Jorge ManzoJorge Manzo
Jorge Manzo

22 April 2024 in NeuroSci
Verified
Journal Article
Open access
PDF file
BFBernardo Sebastian Flores-Prieto
Bernardo Sebastian Flores-Prieto
FCFlower Caycho
Flower Caycho
Jorge ManzoJorge Manzo
Jorge Manzo
MHMaria Elena Hernandez-Aguilar
Maria Elena Hernandez-Aguilar
Genaro Alfonso Coria-AvilaGenaro Alfonso Coria-Avila
Genaro Alfonso Coria-Avila
María Rebeca Toledo-CardenasMaría Rebeca Toledo-Cardenas
María Rebeca Toledo-Cardenas
The etiology of autism spectrum disorder (ASD) has been linked to both genetic and epigenetic factors. Among the epigenetic factors, exposure to valproic acid (VPA), an antiepileptic and mood-modulating drug, has been shown to induce characteristic traits of ASD when exposed to during embryogenesis. Conversely, in animal models, enriched environment (EE) has demonstrated positive behavioral and neural effects, suggesting its potential as a complementary treatment to pharmacological approaches in central nervous system disorders. In this study, we utilized zebrafish to model ASD characteristics induced by VPA and hypothesized that sensory stimulation through EE could ameliorate the behavioral and neuroanatomical features associated with ASD. To test this hypothesis, we assessed social behavior, cerebellar volume, and Purkinje cell populations via histology and immunohistochemistry after exposing the fish to EE. The results revealed that zebrafish exposed to VPA exhibited social deficits, reduced cerebellar cortex volume, and a decrease in c-Fos-positive cells in the Purkinje layer. In contrast, VPA-exposed fish treated with EE showed increased socialization, augmented cerebellar cortex volume, and an elevation in c-Fos-positive Purkinje cells. These findings suggest that alterations induced by VPA may be ameliorated through EE treatment, highlighting the potential therapeutic impact of sensory stimulation in conditions related to ASD.